MAIA Biotechnology, Inc.
AMEX: MAIA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Vlad Vitoc
- Employees
- 13
- Headquarters
- Chicago, United States
- IPO year
- 2022
- Market cap
- $85.1M
- Website
- https://www.MAIABiotech.com
Loading MAIA…
Loading profile data…Frequently asked questions about MAIA
What does MAIA Biotechnology, Inc. (MAIA) do?
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomere...
Where does MAIA trade?
MAIA Biotechnology, Inc. (MAIA) trades on the New York Stock Exchange American.
What sector is MAIA in?
MAIA Biotechnology, Inc. (MAIA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MAIA Biotechnology, Inc.?
Vlad Vitoc is the chief executive officer of MAIA Biotechnology, Inc. (MAIA).
Where is MAIA Biotechnology, Inc. headquartered?
MAIA Biotechnology, Inc. is headquartered in United States.
Does MAIA pay a dividend?
MAIA Biotechnology, Inc. (MAIA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MAIA go public?
MAIA Biotechnology, Inc. (MAIA) completed its initial public offering in 2022.